Page last updated: 2024-11-01

nimodipine and Opioid-Related Disorders

nimodipine has been researched along with Opioid-Related Disorders in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Opioid-Related Disorders: Disorders related to or resulting from abuse or misuse of OPIOIDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosse, RB1
Alim, TN1
Fay-McCarthy, M1
Collins, JP1
Vocci, FJ1
Lindquist, T1
Jentgen, C1
Hess, AL1
Deutsch, SI1

Trials

1 trial available for nimodipine and Opioid-Related Disorders

ArticleYear
Nimodipine pharmacotherapeutic adjuvant therapy for inpatient treatment of cocaine dependence.
    Clinical neuropharmacology, 1994, Volume: 17, Issue:4

    Topics: Calcium Channel Blockers; Chemotherapy, Adjuvant; Crack Cocaine; Double-Blind Method; Humans; Inpati

1994